Xarelto Lawsuit Plaintiffs Note Lack Of Antidote At Time Of Drug’s Release To Market

June 23, 2016 – – TheProductLawyers.com announces that case selection in the mass litigation against Xarelto began earlier this year. The bellwether action brings the more than 2,200 suits represented by multidistrict litigation (MDL) 2952 before Judge Eldon Fallon, presiding in the Eastern District of Louisiana, who will determine the nature of the allegations against the new-generation anticoagulant.

Initially hailed as a breakthrough in the treatment of blood clots and attendant complications, critics now call Xarelto the most dangerous blood thinner on the market today. In many ways, the anticoagulant stood above the more established treatment options because it offered patients more freedoms than the previous blood thinners before it. Unfortunately, when Xarelto was released to the market it did not have an accompanying antidote as other anticoagulants had.

If a bleeding event occurs, the physician administering a traditional blood thinner can treat their patient with vitamin K. This reverses the drug’s impact and permits the body to clot blood. While blood clots in the circulatory system can be fatal, inability to clot a wound or internal rupture can also be deadly.

Physicians treating patients on Xarelto had to consider surgery or other drastic, life-saving measures in the event of bleeding because the impact of the drug could not be counteracted. This meant that clotting could not occur and a catastrophic bleeding episode could result in death. Xarelto was on the market for several years without a corresponding antidote, a point that many plaintiffs involved in the MDL note. Plaintiffs involved in Xarelto multidistrict litigation also allege that the drug put them at an increased risk for dangerous, uncontrollable bleeding.

While selection for the bellwether case began earlier in 2016, information about the potential issues involved with Xarelto use is becoming more widespread. This may result in additional cases being brought against the manufacturers of the anticoagulant in the coming year, as those who claim to have suffered harm while on Xarelto seek damages.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010979